| 0 |
DEPOSIT EYE |
3 |
| 1 |
RASH |
3 |
| 2 |
WEIGHT INCREASED |
3 |
| 3 |
ARTHRALGIA |
2 |
| 4 |
CORNEAL OPACITY |
2 |
| 5 |
DIARRHOEA |
2 |
| 6 |
DRUG INEFFECTIVE |
2 |
| 7 |
EYE IRRITATION |
2 |
| 8 |
EYE PAIN |
2 |
| 9 |
FUNGAL INFECTION |
2 |
| 10 |
HORDEOLUM |
2 |
| 11 |
HYPOAESTHESIA |
2 |
| 12 |
INFECTION |
2 |
| 13 |
MUSCULOSKELETAL PAIN |
2 |
| 14 |
OCULAR HYPERAEMIA |
2 |
| 15 |
OFF LABEL USE |
2 |
| 16 |
PERIPHERAL SWELLING |
2 |
| 17 |
PRODUCT RESIDUE PRESENT |
2 |
| 18 |
VISUAL IMPAIRMENT |
2 |
| 19 |
ABDOMINAL DISTENSION |
1 |
| 20 |
ADVERSE EVENT |
1 |
| 21 |
ADVERSE REACTION |
1 |
| 22 |
AGEUSIA |
1 |
| 23 |
ALOPECIA |
1 |
| 24 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1 |
| 25 |
ARTHROPATHY |
1 |
| 26 |
ASTHENIA |
1 |
| 27 |
BACK INJURY |
1 |
| 28 |
BACK PAIN |
1 |
| 29 |
BLEPHAROSPASM |
1 |
| 30 |
BLINDNESS |
1 |
| 31 |
BLISTER |
1 |
| 32 |
BLOOD CHOLESTEROL INCREASED |
1 |
| 33 |
BREAST CANCER STAGE III |
1 |
| 34 |
BURSITIS |
1 |
| 35 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
| 36 |
C-REACTIVE PROTEIN INCREASED |
1 |
| 37 |
COELIAC DISEASE |
1 |
| 38 |
CONDITION AGGRAVATED |
1 |
| 39 |
CONFUSIONAL STATE |
1 |
| 40 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
| 41 |
CORNEAL DEPOSITS |
1 |
| 42 |
DARK CIRCLES UNDER EYES |
1 |
| 43 |
DEPRESSION |
1 |
| 44 |
DIZZINESS |
1 |
| 45 |
DRUG HYPERSENSITIVITY |
1 |
| 46 |
DRUG-INDUCED LIVER INJURY |
1 |
| 47 |
DRY MOUTH |
1 |
| 48 |
DUODENAL ULCER PERFORATION |
1 |
| 49 |
DYSPEPSIA |
1 |
| 50 |
DYSPNOEA |
1 |
| 51 |
EPILEPSY |
1 |
| 52 |
EXOSTOSIS |
1 |
| 53 |
EXPOSURE DURING PREGNANCY |
1 |
| 54 |
EXPOSURE KERATITIS |
1 |
| 55 |
EYE INFECTION |
1 |
| 56 |
EYE SWELLING |
1 |
| 57 |
EYELID PAIN |
1 |
| 58 |
FACET JOINT SYNDROME |
1 |
| 59 |
FALL |
1 |
| 60 |
FATIGUE |
1 |
| 61 |
FIBROMYALGIA |
1 |
| 62 |
FINGER DEFORMITY |
1 |
| 63 |
FOLLICULITIS |
1 |
| 64 |
GAIT DISTURBANCE |
1 |
| 65 |
GAIT INABILITY |
1 |
| 66 |
GASTROINTESTINAL DISORDER |
1 |
| 67 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
| 68 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
| 69 |
GLOSSODYNIA |
1 |
| 70 |
GRIP STRENGTH DECREASED |
1 |
| 71 |
HAND DEFORMITY |
1 |
| 72 |
HEADACHE |
1 |
| 73 |
HELICOBACTER INFECTION |
1 |
| 74 |
HEPATIC CIRRHOSIS |
1 |
| 75 |
HEPATIC ENZYME INCREASED |
1 |
| 76 |
HEPATITIS |
1 |
| 77 |
HYPERCHOLESTEROLAEMIA |
1 |
| 78 |
HYPERSENSITIVITY |
1 |
| 79 |
HYPERTENSION |
1 |
| 80 |
ILL-DEFINED DISORDER |
1 |
| 81 |
IMPAIRED HEALING |
1 |
| 82 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
| 83 |
INFLAMMATION |
1 |
| 84 |
INFUSION RELATED REACTION |
1 |
| 85 |
INFUSION SITE REACTION |
1 |
| 86 |
INJECTION SITE REACTION |
1 |
| 87 |
INJURY |
1 |
| 88 |
INSOMNIA |
1 |
| 89 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
| 90 |
IRRITABLE BOWEL SYNDROME |
1 |
| 91 |
JOINT RANGE OF MOTION DECREASED |
1 |
| 92 |
JOINT STIFFNESS |
1 |
| 93 |
JOINT SWELLING |
1 |
| 94 |
LARYNGITIS |
1 |
| 95 |
LIP DRY |
1 |
| 96 |
LIVE BIRTH |
1 |
| 97 |
LIVER DISORDER |
1 |
| 98 |
LIVER FUNCTION TEST INCREASED |
1 |
| 99 |
LIVER INJURY |
1 |
| 100 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
| 101 |
LOWER LIMB FRACTURE |
1 |
| 102 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
| 103 |
LUNG DISORDER |
1 |
| 104 |
LUPUS-LIKE SYNDROME |
1 |
| 105 |
MALAISE |
1 |
| 106 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
| 107 |
MEMORY IMPAIRMENT |
1 |
| 108 |
MIGRAINE |
1 |
| 109 |
MOBILITY DECREASED |
1 |
| 110 |
MUSCLE INJURY |
1 |
| 111 |
MUSCLE SPASMS |
1 |
| 112 |
MUSCULAR WEAKNESS |
1 |
| 113 |
MUSCULOSKELETAL STIFFNESS |
1 |
| 114 |
NAIL DISORDER |
1 |
| 115 |
NASOPHARYNGITIS |
1 |
| 116 |
NAUSEA |
1 |
| 117 |
NECK PAIN |
1 |
| 118 |
NIGHT SWEATS |
1 |
| 119 |
NORMAL NEWBORN |
1 |
| 120 |
OBESITY |
1 |
| 121 |
OEDEMA |
1 |
| 122 |
ONYCHOMADESIS |
1 |
| 123 |
ONYCHOMYCOSIS |
1 |
| 124 |
OSTEOARTHRITIS |
1 |
| 125 |
OVERDOSE |
1 |
| 126 |
PAIN IN EXTREMITY |
1 |
| 127 |
PEMPHIGUS |
1 |
| 128 |
PERICARDITIS |
1 |
| 129 |
PERIPHERAL VENOUS DISEASE |
1 |
| 130 |
PNEUMONIA |
1 |
| 131 |
PRODUCT LABEL CONFUSION |
1 |
| 132 |
PRODUCT STERILITY LACKING |
1 |
| 133 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
| 134 |
PRODUCT USE ISSUE |
1 |
| 135 |
PRURITUS GENERALISED |
1 |
| 136 |
PSORIATIC ARTHROPATHY |
1 |
| 137 |
PULMONARY FIBROSIS |
1 |
| 138 |
PYREXIA |
1 |
| 139 |
RECALLED PRODUCT ADMINISTERED |
1 |
| 140 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
| 141 |
RESPIRATORY DISORDER |
1 |
| 142 |
RHEUMATIC FEVER |
1 |
| 143 |
RHEUMATOID ARTHRITIS |
1 |
| 144 |
RHEUMATOID FACTOR POSITIVE |
1 |
| 145 |
SCIATICA |
1 |
| 146 |
SENSORY DISTURBANCE |
1 |
| 147 |
SINUSITIS |
1 |
| 148 |
SKIN EXFOLIATION |
1 |
| 149 |
SKIN MASS |
1 |
| 150 |
SLEEP DISORDER |
1 |
| 151 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE |
1 |
| 152 |
STOMATITIS |
1 |
| 153 |
SWELLING |
1 |
| 154 |
SYNOVITIS |
1 |
| 155 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
| 156 |
TASTE DISORDER |
1 |
| 157 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
| 158 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
| 159 |
TREATMENT FAILURE |
1 |
| 160 |
UNDERDOSE |
1 |
| 161 |
URINARY TRACT INFECTION |
1 |
| 162 |
URTICARIA |
1 |
| 163 |
VOMITING |
1 |
| 164 |
WHEEZING |
1 |
| 165 |
WOUND |
1 |
| 166 |
WOUND INFECTION |
1 |